Summary
The National Allergy Strategy represents the first coordinated UK‑wide framework for improving allergy prevention, diagnosis, management and patient safety. It has been shaped through extensive consultation across the allergy community, including clinicians, patients and charities, and reflects both lived experience and frontline clinical realities.
The strategy outlines the key objectives and priority projects needed to improve health outcomes and other unmet needs of the allergy community across the UK.
The National Allergy Strategy Group (NASG) is an alliance of the professional organisations BSACI (British Society of Allergy and Clinical Immunology) and the patient charities, Allergy UK, Anaphylaxis UK and Natasha Allergy Research Foundation (NARF).
Content
Intended outcomes
- Reduced preventable harm, including fewer avoidable deaths and severe allergic reactions, through safer environments and earlier, more consistent intervention.
- Improved health outcomes and quality of life for people living with allergic disease, with greater safety, inclusion and confidence in everyday life.
- Reduced health and social inequalities, ensuring protection, access to care and quality of support do not depend on geography, background or individual advocacy.
- Equitable access to high-quality, lifelong allergy care across all four nations, supported by consistent standards, safer transitions between services, and timely access to effective treatments.
- A sustainable, skilled workforce and system capability, with allergy embedded in service planning, professional education and community provision to meet growing need.
- Better value for money for the NHS and wider public services, achieved through prevention, early intervention, improved data and surveillance, and more efficient use of resources.
Further reading on the hub:
Recommended Comments
Create an account or sign in to comment